Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Sarmiento, Jose ^a,b   Shumate, Christie ^a   Suetomi, Katsutoshi ^c   Ravindran, Aishwarya ^a   Villegas, León ^d   Rajarathnam, Krishna ^a   Navarro, Javier ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR1 AGONIST; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 AGONIST; INTERLEUKIN 8; UNCLASSIFIED DRUG; CALCIUM; CHEMOKINE; MUTANT PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE; RABBIT; SKIN INFLAMMATION; CELL STRAIN HL 60; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG POTENTIATION; ENDOCYTOSIS; METABOLISM; PROTEIN BINDING;

CALCIUM; CHEMOKINES; ENDOCYTOSIS; HL-60 CELLS; HUMANS; MODELS, MOLECULAR; MUTANT PROTEINS; NEUTROPHILS; PROTEIN BINDING; PROTEIN ENGINEERING; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8A;

EID: 83055173255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027967     Document Type: Article

References (21)

1. Sallusto F, Baggiolini M, (2008) Chemokines and leukocyte traffic. Nat Immunol 9: 949-952.
2. Clore GM, Gronenborn AM, (1995) Three-dimensional structures of alpha and beta chemokines. FASEB J 9: 57-62.
3. Milatovic S, Nanney LB, Yu Y, White JR, Richmond A, (2003) Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen 11: 213-219.
4. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273: 10095-10098.
5. Lee J, Cacalano G, Camerato T, Toy K, Moore MW, et al. (1995) Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 155: 2158-2164.
6. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, et al. (2007) Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13: 1423-1430.
7. Ragnarsdottir B, Fischer H, Godaly G, Gronberg-Hernandez J, Gustafsson M, et al. (2008) TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest 38 (Suppl 2): 12-20.
8. Rajagopalan L, Rajarathnam K, (2006) Structural basis of chemokine receptor function-a model for binding affinity and ligand selectivity. Biosci Rep 26: 325-339.
9. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M, (1993) Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci U S A 90: 3574-3577.
10. Kraemer S, Lue H, Zernecke A, Kapurniotu A, Andreetto E, et al. (2011) MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism. FASEB J 25: 894-906.
11. Joseph PR, Sarmiento JM, Mishra AK, Das ST, Garofalo RP, et al. (2010) Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem 285: 29262-29269.
12. Prado GN, Thomas KM, Suzuki H, LaRosa GJ, Wilkinson N, et al. (1994) Molecular characterization of a novel rabbit interleukin-8 receptor isotype. J Biol Chem 269: 12391-12394.
13. Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, et al. (2004) Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Biochem Pharmacol 68: 1947-1955.
14. Lu ZH, Wang ZX, Horuk R, Hesselgesser J, Lou YC, et al. (1995) The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 270: 26239-26245.
15. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, et al. (1992) Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 267: 25402-25406.
16. Suzuki H, Prado GN, Wilkinson N, Navarro J, (1994) The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8. J Biol Chem 269: 18263-18266.
17. Ahuja SK, Lee JC, Murphy PM, (1996) CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J Biol Chem 271: 225-232.
18. Lowman HB, Slagle PH, DeForge LE, Wirth CM, Gillece-Castro BL, et al. (1996) Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol Chem 271: 14344-14352.
19. Baggiolini M, (1998) Chemokines and leukocyte traffic. Nature 392: 565-568.
20. Suetomi K, Lu Z, Heck T, Wood TG, Prusak DJ, et al. (1999) Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes. J Biol Chem 274: 11768-11772.
21. Forrest MJ, Jose PJ, Williams TJ, (1986) Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity. Br J Pharmacol 89: 719-730.